Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor

Ducancel, 2005, Endothelin-like peptides, Cell Mol Life Sci, 62, 2828, 10.1007/s00018-005-5286-x

Rubanyi, 1994, Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology, Pharmacol Rev, 46, 325

Thorin, 2010, The cardiovascular physiology and pharmacology of endothelin-1, Adv Pharmacol, 60, 1, 10.1016/B978-0-12-385061-4.00001-5

Khimji, 2010, Endothelin--biology and disease, Cell Signal, 22, 1615, 10.1016/j.cellsig.2010.05.002

Brunner, 2006, Cardiovascular endothelins: essential regulators of cardiovascular homeostasis, Pharmacol Ther, 111, 508, 10.1016/j.pharmthera.2005.11.001

Haynes, 1994, Contribution of endogenous generation of endothelin-1 to basal vascular tone, Lancet, 344, 852, 10.1016/S0140-6736(94)92827-4

Masaki, 1995, Possible role of endothelin in endothelial regulation of vascular tone, Annu Rev Pharmacol Toxicol, 35, 235, 10.1146/annurev.pa.35.040195.001315

Baynash, 1994, Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons, Cell, 79, 1277, 10.1016/0092-8674(94)90018-3

Meidan, 2007, The ovarian endothelin network: an evolving story, Trends Endocrinol Metab, 18, 379, 10.1016/j.tem.2007.09.002

Griswold, 1999, Endothelin B receptor modulates inflammatory pain and cutaneous inflammation, Mol Pharmacol, 56, 807

Cardillo, 1999, Role of endothelin in the increased vascular tone of patients with essential hypertension, Hypertension, 33, 753, 10.1161/01.HYP.33.2.753

Salani, 2000, Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo, Am J Pathol, 157, 1703, 10.1016/S0002-9440(10)64807-9

Spinella, 2010, Endothelin axis induces metalloproteinase activation and invasiveness in human lymphatic endothelial cells, Can J Physiol Pharmacol, 88, 782, 10.1139/Y10-050

Binder, 2009, Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis, Mol Cancer Ther, 8, 2452, 10.1158/1535-7163.MCT-09-0032

Buckanovich, 2008, Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy, Nat Med, 14, 28, 10.1038/nm1699

Kandalaft, 2011, Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance, Cancer Metastasis Rev, 30, 141, 10.1007/s10555-011-9289-9

Bagnato, 1998, Endothelins as autocrine regulators of tumor cell growth, Trends Endocrinol Metab, 9, 378, 10.1016/S1043-2760(98)00094-0

Demunter, 2001, Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma, Virchows Arch, 438, 485, 10.1007/s004280000362

Lahav, 1999, An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo, Proc Natl Acad Sci USA, 96, 11496, 10.1073/pnas.96.20.11496

Naidoo, 2005, Localization of the endothelin system in human diffuse astrocytomas, Cancer, 104, 1049, 10.1002/cncr.21277

Bagnato, 2004, Endothelin receptors as novel targets in tumor therapy, J Transl Med, 2, 16, 10.1186/1479-5876-2-16

Hutchings, 2010, Therapeutic antibodies directed at G protein-coupled receptors, MAbs, 2, 594, 10.4161/mabs.2.6.13420

Kozer, 2011, Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimmers and oligomers, Biochem, 10, 3581, 10.1021/bi101785h

Carter, 2006, Potent antibody therapeutics by design, Nat Rev Immunol, 6, 343, 10.1038/nri1837

Iannello, 2005, Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies, Cancer Metastasis Rev, 24, 487, 10.1007/s10555-005-6192-2

Reichert, 2005, Monoclonal antibody successes in the clinic, Nat Biotechnol, 23, 1073, 10.1038/nbt0905-1073

Costagliola, 1998, Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor, J Immunol, 160, 1458, 10.4049/jimmunol.160.3.1458

Kaptein, 2008, Generation of polyclonal antibodies directed against G protein-coupled receptors using electroporation-aided DNA immunization, J Pharmacol Toxicol Methods, 58, 27, 10.1016/j.vascn.2007.11.002

Allard, 2011, Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor, DNA Cell Biol, 30, 727, 10.1089/dna.2011.1239

Pedram, 1997, Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion, J Biol Chem, 272, 17097, 10.1074/jbc.272.27.17097

Shichiri, 1997, Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells, Hypertension, 30, 1198, 10.1161/01.HYP.30.5.1198

Pierce, 2002, Seven-transmembrane receptors, Nat Rev Mol Cell Biol, 3, 639, 10.1038/nrm908

Schlyer, 2006, I want a new drug: G-protein-coupled receptors in drug development, Drug Discov Today, 11, 481, 10.1016/j.drudis.2006.04.008

Lagerström, 2008, Structural diversity of G protein-coupled receptors and significance for drug discovery, Nat Rev Drug Discov, 7, 339, 10.1038/nrd2518

Fujimoto, 2009, Production of human antibodies to native cytokine receptors using the genetic immunization of KM mice, Hum Antibodies, 18, 75, 10.3233/HAB-2009-0205

Takatsuka, 2011, Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization, J Pharmacol Toxicol Methods, 63, 250, 10.1016/j.vascn.2010.12.003

Tymciu, 2002, Use of DNA immunization to produce polyclonal antibodies against the native human neurokinin-1 receptor for substance P, J Neuroimmunol, 128, 23, 10.1016/S0165-5728(02)00115-7

Spinella, 2012, Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells, J Mol Med (Berl)

Erdmann, 2009, Kinetic Study of Human Full-Length Wild-Type JAK2 and V617F Mutant Proteins, TOEIJ, 1, 80, 10.2174/1874940200801010080

Ruf, 2007, Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer, Br J Cancer, 97, 315, 10.1038/sj.bjc.6603881

Däumer, 2011, Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity, Med Microbiol Immunol, 200, 85, 10.1007/s00430-010-0174-x

Aubin, 2008, Identification of ETA and ETB binding domains using ET-derived photoprobes, Biochimie, 90, 918, 10.1016/j.biochi.2008.02.015

Lättig, 2009, Structural determinants for selective recognition of peptide ligands for endothelin receptor subtypes ETA and ETB, J Pept Sci, 15, 479, 10.1002/psc.1146

Kondoh, 1990, Isolation of anti-endothelin receptor monoclonal antibodies for use in receptor characterization, Biochem Biophys Res Commun, 172, 503, 10.1016/0006-291X(90)90701-N

Yamaguchi, 2004, Characterization and application of monoclonal antibodies against human endothelin B receptor expressed in insect cells, Biotechnol Lett, 26, 293, 10.1023/B:BILE.0000015428.68786.39

Asundi, 2011, An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma, Clin Cancer Res, 17, 965, 10.1158/1078-0432.CCR-10-2340

Kusuhara, 1990, Production of endothelin in human cancer cell lines, Cancer Res, 50, 3257

Bagnato, 1995, Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells, Clin Cancer Res, 1, 1059

Akiyama, 1992, Biotin derivatives of endothelin: utilization for affinity purification of endothelin receptor, Protein Expr Purif, 3, 427, 10.1016/S1046-5928(05)80046-4

Grantcharova, 2002, The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process, J Biol Chem, 277, 43933, 10.1074/jbc.M208407200

Grantcharova, 2006, N-terminal proteolysis of the endothelin B receptor abolishes its ability to induce EGF receptor transactivation and contractile protein expression in vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 26, 1288, 10.1161/01.ATV.0000220377.51354.30

Giricz, 2010, Variability in melanoma metalloproteinase expression profiling, J Biomol Tech, 21, 194

Tsutsumi, 1999, Novel endothelin B receptor transcripts with the potential of generating a new receptor, Gene, 228, 43, 10.1016/S0378-1119(99)00014-1

Pao, 2001, The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells, Hum Mol Genet, 10, 903, 10.1093/hmg/10.9.903

Evans, 2008, Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization, Biophys J, 95, 483, 10.1529/biophysj.107.119206

Grassi, 1988, Screening of monoclonal antibodies using antigens labeled with acetylcholinesterase: application to the peripheral proteins of photosystem 1, Anal Biochem, 168, 436, 10.1016/0003-2697(88)90341-7

Laune, 2002, Application of the Spot method to the identification of peptides and amino acids from the antibody paratope that contribute to antigen binding, J Immunol Methods, 267, 53, 10.1016/S0022-1759(02)00140-0